Lifecore Biomedical Inc. - Aset Bersih saben Siji Saham LFCR

The daily price chart for Lifecore Biomedical (LFCR) reflects the asset's dynamics, with its value currently at -0.90. The business relies on predictive reagent inventory control to eliminate downtime, while operational activities remain heavily dependent on external biomaterial suppliers. The company's high standing is confirmed by the trust of market leaders, driven by its expertise in hyaluronate production and impeccable quality control.

Lifecore (LFCR): Nilai Buku Saham saka 28.04.2023 nganti 26.10.2026

Lifecore Biomedical Inc. - rincian analitis lan metrik utama (LFCR)

- rega lan prakiraan konsensus rega:

Rega saham Lifecore|LFCR - Target konsensus

- data kapitalisasi pasar:

Nilai pasar Lifecore Biomedical, Inc.|LFCR - Nilai Dipunlarasaken Utang lan Kas

- data kapitalisasi buku:

Aset Bersih saben Siji Saham Lifecore Biomedical|LFCR - Nilai Aset Bersih|Rasio Kapitalisasi Pasar marang Nilai Buku lifecore.com|LFCR - Nilai Agregat Aset

- data utang lan likuiditas:

Total Utang marang Modal Lifecore Biomedical|LFCR - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Lifecore|LFCR - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku Lifecore Biomedical, Inc.

Pambiji fundamental perusahaan:lifecore.com - LFCR

For Lifecore Biomedical (LFCR), whose resilience relies on strict FDA compliance and long-term sterile injectable contracts, net assets serve as an objective measure of the business's intrinsic value. Analyzing the book value per share allows for a comparison between the market price and actual capital minus liabilities, revealing the undervaluation of securities during periods of volatility and confirming the quality of the company's tangible asset base.

Pesaing Lifecore Biomedical (LFCR)